Topic: MS

New consensus statement on MRI biomarkers in MS

February 20, 2024  

No benefit with adjuvant vitamin D in MS: meta-analysis

February 12, 2024  

McDonald criteria 2024: what changes can we expect?

January 30, 2024  

First-line anti-CD20 therapy – the new standard of care in MS?

January 25, 2024  

MS Awards 2023 – Oddities and observations

December 19, 2023  

The year in review – 2023

December 12, 2023  

NfL a marker of microglial activation

December 6, 2023  

Biomarkers after stopping treatment may identify at-risk MS patients

November 30, 2023  

Exploring the lung-brain axis in MS

November 29, 2023  

Neurofilament-light chain (NfL) as a biomarker of response to higher-efficacy disease-modifying therapies

November 22, 2023